The IL-15-Based ALT-803 Complex Enhances FcγRIIIa-Triggered NK Cell Responses and <i>In Vivo</i> Clearance of B Cell Lymphomas
Maximillian Rosario(Washington University in St. Louis), Todd A. Fehniger(Washington University in St. Louis), Jeffrey Leong(Washington University in St. Louis), Brian Hess(Washington University in St. Louis), Brea A. Jewell(Washington University in St. Louis), David Piwnica‐Worms(The University of Texas MD Anderson Cancer Center), Kaiping Han(Altor BioScience (United States)), Lynne Collins(Mallinckrodt (United States)), Peter R. Rhode(Altor BioScience (United States)), Timothy Schappe(Washington University in St. Louis), Rizwan Romee(Harvard University), Emily K. Jeng(Altor BioScience (United States)), Xiaoyue Chen(Sichuan Agricultural University), Hing C. Wong(Altor BioScience (United States)), Nancy L. Bartlett(Washington University in St. Louis), Catherine R. Keppel, Bai Liu(Altor BioScience (United States)), Keval Shah(Washington University in St. Louis), Stephanie Schneider(Washington University in St. Louis), Lin Kong(Altor BioScience (United States)), Amanda F. Cashen(Washington University in St. Louis)
Cited by 147
Related Papers
Genetics and Pathogenesis of Diffuse Large B-Cell Lymphoma
|New England Journal of Medicine|2018|2.3k
Ibrutinib as Initial Therapy for Patients with Chronic Lymphocytic Leukemia
|New England Journal of Medicine|2015|1.6k